Sitemap - 2024 - Craig Willy’s Evopolitics
Repronews #59: Denmark now providing women IVF for up to 2 children
The Rise & Evolution of the USA: Visualized
In “Aporia”: When Confucius met Darwin
Repronews #58: South-African bioethicists defend therapeutic human gene editing
Repronews #57: Preimplantation genetic testing market to almost double by 2031
Messianism as evolutionary adaptation
Talking Trump 2.0 with Brussels Signal
Repronews #56: Will the next pandemic be AI-generated?
Repronews #55: Polygenic screening could cut early disease deaths by 25%
Repronews #54: Does gene editing violate human dignity?
Repronews #53: South Africa’s new guidelines allow heritable gene editing
American Ideologies Past, Present, and Future
Talking U.S. Politics on France’s Radio Courtoisie
Repronews #52: Is the Blank Slate doomed?
Who will win the U.S.-China scientific race?
Progress and stasis in the war on cancer
Repronews #51: China’s fertility crash
Repronews #50: Is human gene editing moral?
Repronews #49: European Coalition for Fertility launched
Repronews #48: 20,000 babies born under Taiwan IVF subsidy program
Europe’s Demographic Outlook: Insights from the Martens Centre
Repronews #47: California to require insurance companies to pay for IVF
American Visionary: Benjamin Franklin’s Strategy for the Peopling of a Continent
Repronews #46: California, “VIP fertility” capital of the world
Repronews #45: IVF bills fail in Senate
Inaugural Podcast: Evopolitics 101
Repronews #44: This is Evopolitics
In “Aporia”: On Techno-Natalism in Israel
Charles de Gaulle on Order, Progress... and Why Liberalism Wins
Oliver Wendell Holmes, American Nietzschean
Did Denmark really curb immigration?
Churchill’s Dream: An Anglosphere Union
In “Palladium Magazine”: On the Demographic Roots of American Power
Visualized: The Global Biotech Race
Acumen Analysis: Towards an EU Biotech Act?
NatSec & Biotech #5: U.S. politicians raise alarm on China biotech risks
Visualized: Biotech’s Economic Footprint in Europe
NatSec & Biotech #4: the food issue
NatSec & Biotech #3: 10,000 Indian genomes
NatSec & Biotech #2: The four-trillion-dollar question
The CRISPR crop revolution crashes Europe